Online solid phase extraction liquid chromatography method for detecting clonazepam content in blood
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- BEIJING HARMONY HEALTH MEDICAL DIAGNOSTICS CO LTD
- Publication Date
- 2018-08-24
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of clinical blood drug concentration monitoring of psychotropic drugs, in particular to a method for detecting the concentration of clonazepam, an antiepileptic and anticonvulsant drug in blood. Background technique
[0002] Epilepsy is a common neurological disease characterized by sudden and recurrent seizures. Currently, drug therapy is the first choice in clinical practice. Clonazepam is a broad-spectrum antiepileptic drug, used to control various types of epileptic seizures, and has a better effect on absence seizures, infantile spasms, myoclonic and akinetic seizures. It can also be used in the treatment of drug-induced attention deficit disorder (hyperactivity disorder) and various neuralgia. The active compound circulating in the blood is clonazepam after it passes through the gastrointestinal tract after oral administration. Clonazepam (Clonazepam, CZP), the molecular formula is C 15 h 10 ClN 3...